Paul Actor
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 33
- Antibiotics Pharmacokinetics and Efficacy 26
-
- Phenothiazines and Benzothiazines Synthesis and Activities 11
- Cancer therapeutics and mechanisms 5
- Co-authors
- Jerry A. Weisbach (24 shared papers)Donald Pitkin (16 shared papers)George L. Dunn (8 shared papers)John R. E. Hoover (8 shared papers)Ian Zajac (6 shared papers)Sarah F. Grappel (9 shared papers)Robert M. DeMarinis (3 shared papers)John F. Pauls (3 shared papers)
- Journals
- The Journal of Antibiotics (21 papers)Antimicrobial Agents and Chemotherapy (10 papers)Journal of Clinical Microbiology (4 papers)Infection and Immunity (4 papers)Cellular and Molecular Life Sciences (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Paul Actor
68 papers receiving 797 citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 173
- Pharmacology 311
- Endocrinology 67
- Infectious Diseases 224
- Microbiology 60
Countries citing papers authored by Paul Actor
This map shows the geographic impact of Paul Actor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Actor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Actor more than expected).
Fields of papers citing papers by Paul Actor
This network shows the impact of papers produced by Paul Actor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Actor. The network helps show where Paul Actor may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Actor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibiotic inhibition of bacterial cell surface assembly and function | 1988 | 191 |
| 2 | 1978 | 51 | |
| 3 | 1975 | 45 | |
| 4 | 1981 | 43 | |
| 5 | 1984 | 36 | |
| 6 | 1967 | 32 | |
| 7 | 1972 | 30 | |
| 8 | 1960 | 27 | |
| 9 | 2003 | 25 | |
| 10 | 1985 | 23 | |
| 11 | 1976 | 22 | |
| 12 | 1974 | 20 | |
| 13 | 1966 | 20 | |
| 14 | 1983 | 19 | |
| 15 | 1985 | 18 | |
| 16 | 1977 | 18 | |
| 17 | 1982 | 16 | |
| 18 | 1974 | 15 | |
| 19 | 1975 | 15 | |
| 20 | 1971 | 15 |
About Paul Actor
Paul Actor is a scholar working on Pharmacology, Molecular Biology, Infectious Diseases, Molecular Medicine and Organic Chemistry, having authored 72 papers that have together received 988 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Antibiotic Resistance in Bacteria (15 papers), Phenothiazines and Benzothiazines Synthesis and Activities (11 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antifungal resistance and susceptibility (6 papers), Vibrio bacteria research studies (5 papers), Escherichia coli research studies (5 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Molecular Medicine (173 citations), Pharmacology (311 citations), Endocrinology (67 citations), Infectious Diseases (224 citations) and Microbiology (60 citations). Paul Actor has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jerry A. Weisbach, Donald Pitkin, George L. Dunn, John R. E. Hoover, Ian Zajac, Sarah F. Grappel, Robert M. DeMarinis, John F. Pauls, David A. Berges and William D. Kingsbury. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Infection and Immunity and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.